SCHEMBL10703151

SCHEMBL10703151

C=C1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@@]2(C)C(=C)C(=C)C(=O)C=C12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 8/20 0.47
▸ CYP3A4 P08684 7/20 0.47
▸ NR3C1 P04150 7/20 0.47
▸ AR P10275 7/20 0.47
▸ LMNA P02545 5/20 0.47
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ NPSR1 Q6W5P4 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ CHRM2 P08172 3/20 0.47
▸ ABCB11 O95342 2/20 0.47
▸ CHRM1 P11229 2/20 0.47
▸ USP2 O75604 2/20 0.47
▸ ESR1 P03372 2/20 0.47
▸ ABCC4 O15439 1/20 0.47
▸ SHBG P04278 1/20 0.47
▸ NR3C2 P08235 1/20 0.47
▸ HRH2 P25021 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ AKR1C1 Q04828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703062 0.91 CYP3A4 (0.45) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10705490 0.89 NR3C1 (0.49) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10704398 0.88 CYP3A4 (0.56) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10703731 0.87 LMNA (0.38) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10706233 0.85 NR3C1 (0.42) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10702512 0.84 LMNA (0.46) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10705750 0.83 CYP17A1 (0.53) PGRCYP3A4NR3C1ARLMNA
SCHEMBL11802467 0.82 AR (0.54) PGRCYP3A4NR3C1ARLMNA
SCHEMBL10705008 0.82 NR3C1 (0.63) PGRCYP3A4NR3C1ARLMNA
SCHEMBL853001 0.81 LMNA (0.67) PGRCYP3A4NR3C1ARLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP claimed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US claimed
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback